Drug of Abuse Testing Market is Expected to Reach CAGR of around 9.6% from 2016 to 2022 Says Report by Acumen Research and Consulting Research Experts

Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled Drug of Abuse Testing Market (Product Type: Equipment, Consumables; Sample: Urine, Saliva, Hair, Others; End-user: Hospital, Laboratory, Workplace, At Home, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2012-2022”, forecasts that the global drug of abuse testing market is anticipated to grow at a CAGR of around 9.6% from 2016 to 2022 and reach the market value of over $8 billion by 2022. Globally, North America accounted for the largest share in 2015 and is expected to maintain its dominance throughout the forecast period. This is due to the increasing availability of illegitimate drugs, growth in drug trafficking, and increase in workplace checking for the consumption of barred drugs. Asia-Pacific is expected to witness fastest growth during the forecast period, at a CAGR of around 10% from 2016-2022.

Download Sample Pages – https://www.acumenresearchandconsulting.com/request-sample/384

The global drug of abuse testing market is growing at a significant rate due to increased usage of drug of abuse testing at organizational levels and increased production and trade of illicit drugs worldwide. In addition, global increase in road accidents and death rates, increase in the consumption of illegal drugs and technological advancements in drug of abuse testing further drives the market. The increased production and trafficking of illegal drugs is expected to increase the demand for drugs of abuse testing. According to the UN Office on Drugs and Crime (UNODC), area under opium cultivation increased from approximately 209,000 hectare in 2013 to 224,000 hectare in 2014, which is approximately 7% increase. The extent of drug seizure can be used as an indirect measure of increased trade of illicit drugs worldwide. For instance, according to UNODC, since 2002 Afghanistan, Iran and Pakistan have accounted for more than 90% opium seized across the globe, and this pattern also continued in 2013. Similarly, according to UNODC, approximately 40 tons of cocaine was seized in 2013 in Brazil. The increase in production and trade of illicit drugs across the globe leads to increased demand for drug of abuse testing.

The global drug of abuse testing market is segmented on the basis of product type, sample, end-user, and geography. Depending on product type, the market is divided into equipment and consumables. Consumables was the largest segment and accounted for more than 50% share in 2015. It is also expected to be the fastest growing product segment during the forecast period. Equipment segment is further divided into immunoassay analyzer, chromatography instrument, and breath analyzers while consumables segment is further divided into rapid test kit, assay kit & reagents, and others. Based on sample, the market is segmented into urine, saliva, hair, and others. The end-user segments of drug of abuse testing market include hospital, laboratory, workplace, at home, and others. The regional markets analyzed in the report include North America, Europe, Asia-Pacific, and Rest of the World.

View Report at https://www.acumenresearchandconsulting.com/drug-of-abuse-testing-market

The market players profiled in the report include Siemens AG, Danaher Corporation, Shimadzu Corporation, MilliporeSigma, Drägerwerk AG & Co. KGAA, Express Diagnostics Int’l, Inc, Psychemedics Corporation, Waters Corporation, BioMerieux SA, F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, Quest Diagnostics Inc, Alere Inc, Randox Laboratories Ltd, Bio-Rad Laboratories, Inc., Abbott Laboratories, Sonic Healthcare Ltd, and Thermo Fisher Scientific Inc. among others. Mergers and acquisitions for innovation and new product development and partnership for enhancing product quality are some of the major strategies followed by leading players in this market to sustain market competition.

Table Of Content

Chapter 1. Research Scope & Methodology

1.1 Market Definition

1.2 Market Scope

1.2.1 Global Drug Of Abuse Testing Market, By Product

1.2.2 Global Drug Of Abuse Testing Market, By Sample

1.2.3 Global Drug Of Abuse Testing Market, By End-User

1.2.4 Global Hospital Bed Market, By Geography

1.3 Research Methodology And Sources

Chapter 2. Executive Summary

2.1 Key Findings

2.2 Research Summary

Chapter 3. Market Outlook

3.1 Introduction

3.2 Market Drivers And Their Impact

3.2.1 Growing Use Of Drug Of Abuse Testing At Organizational Levels

3.2.2 Growing Production And Trade Of Illicit Drugs Worldwide

3.2.3 Rise In Road Accidents And Related Deaths

3.2.4 Rising Consumption Of Illegal Drugs

3.2.5 Technological Advancements

3.2.6 Impact Analysis Of Drivers

3.3 Factors Hindering Market Growth And Its Impact

3.3.1 Legalization Of Drugs

3.3.2 Social Issues Associated With Drug Of Abuse Testing

3.3.3 Inability To Detect Low-Dose Designer Drugs

3.3.4 Impact Analysis Of Restraints

Chapter 4. Global Drug Of Abuse Testing Market Analysis

4.1 Global Drug of Abuse Testing Market, By Product

4.2 Global Drug of Abuse Testing Market, By Sample

4.3 Global Drug of Abuse Testing Market, By End-User

4.4 Global Drug of Abuse Testing Market, By Region

Chapter 5. Global Drug of Abuse Testing Market, By Product

5.1 Drug of Abuse Testing Equipment Market

5.1.1 Drug Of Abuse Testing Equipment Market, By Type

5.1.1.1 Immunoassay Analyzer Market

5.1.1.2 Chromatography Instrument Market

5.1.1.3 Breath Analyzer Market

5.1.2 Drug Of Abuse Testing Equipment Market, By Region

5.2 Drug of Abuse Testing Consumable Market

5.2.1 Drug Of Abuse Testing Consumable Market, By Type

5.2.1.1 Assay Kits And Reagent Market

5.2.1.2 Rapid Test Kits Market

5.2.2 Drug Of Abuse Testing Consumable Market, By Region

Chapter 6. Global Drug of Abuse Testing Market, By Sample

6.1 Urine Based Drug of Abuse Testing Market

6.2 Saliva Based Drug of Abuse Testing Market

6.3 Hair Based Drug of Abuse Testing Market

Chapter 7. Global Drug of Abuse Testing Market, By End-User

7.1 Hospital Based Drug Of Abuse Testing Market

7.2 Laboratory Based Drug Of Abuse Testing Market

7.3 Workplace Based Drug Of Abuse Testing Market

7.4 At Home Drug Of Abuse Testing Market

Chapter 8. Global Drug Of Abuse Testing Market, By Geography

8.1 North America Drug Of Abuse Testing Market

8.1.1 North America Drug Of Abuse Testing Market, By Product

8.1.1.1 North America Drug Of Abuse Testing Equipment Market, By Type

8.1.1.2 North America Drug Of Abuse Testing Consumable Market, By Type

8.1.2 North America Drug Of Abuse Testing Market, By Sample

8.1.3 North America Drug Of Abuse Testing Market, By End-User

8.1.4 North America Drug Of Abuse Testing Market, By Country

8.2 Europe Drug of Abuse Testing Market

8.2.1.1 Europe Drug Of Abuse Testing Equipment Market, By Type

8.2.1.2 Europe Drug Of Abuse Testing Consumable Market, By Type

8.2.2 Europe Drug Of Abuse Testing Market, By Sample

8.2.3 Europe Drug Of Abuse Testing Market, By End-User

8.2.4 Europe Drug Of Abuse Testing Market, By Country

8.3 Asia-Pacific Drug Of Abuse Testing Market

8.3.1 Asia-Pacific Drug Of Abuse Testing Market, By Product

8.3.1.1 Asia-Pacific Drug Of Abuse Testing Equipment Market, By Type

8.3.1.2 Asia-Pacific Drug Of Abuse Testing Consumable Market, By Type

8.3.2 Asia-Pacific Drug Of Abuse Testing Market, By Sample

8.3.3 Asia-Pacific Drug Of Abuse Testing Market, By End-User

8.3.4 Asia-Pacific Drug Of Abuse Testing Market, By Country

8.4 Rest of the World (RoW) Drug of Abuse Testing Market

8.4.1 Row Drug Of Abuse Testing Market, By Product

8.4.1.1 Row Drug Of Abuse Testing Equipment Market, By Type

8.4.1.2 Row Drug Of Abuse Testing Consumable Market, By Type

8.4.2 Row Drug Of Abuse Testing Market, By Sample

8.4.3 Row Drug Of Abuse Testing Market, By End-User

8.4.4 Row Drug Of Abuse Testing Market, By Country

Chapter 9. Competitive Positioning And Market Share Analysis

9.1 Porter’s Five Forces Of Competitive Position Analysis

9.1.1 Bargaining Power Of Buyers

9.1.2 Bargaining Power Of Suppliers

9.1.3 Threat Of New Entrants

9.1.4 Intensity Of Rivalry

9.1.5 Threat Of Substitutes

9.2 Competitive Positioning Of Key Players, 2015

Chapter 10. Company Profiles and Strategic Developments

10.1 Company Profiles

10.1.1 Danaher Corporation

10.1.1.1 Business Overview

10.1.1.2 Product And Service Offerings

10.1.2 Siemens AG

10.1.2.1 Business Overview

10.1.2.2 Product And Service Offerings

10.1.3 MilliporeSigma

10.1.3.1 Business Overview

10.1.3.2 Product And Service Offerings

10.1.4 Shimadzu Corporation

10.1.4.1 Business Overview

10.1.4.2 Product And Service Offerings

10.1.5 Drägerwerk AG & Co. KGaA

10.1.5.1 Business Overview

10.1.5.2 Product And Service Offerings

10.1.6 Express Diagnostics Int’l, Inc.

10.1.6.1 Business Overview

10.1.6.2 Product And Service Offerings

10.1.7 bioMerieux SA

10.1.7.1 Business Overview

10.1.7.2 Product And Service Offerings

10.1.8 Waters Corporation

10.1.8.1 Business Overview

10.1.8.2 Product And Service Offerings

10.1.9 F. Hoffmann-La Roche Ltd

10.1.9.1 Business Overview

10.1.9.2 Product And Service Offerings

10.1.10 Quest Diagnostics Inc.

10.1.10.1 Business Overview

10.1.10.2 Product And Service Offerings

10.1.11 Laboratory Corporation Of America Holdings

10.1.11.1 Business Overview

10.1.11.2 Products And Service Offerings

10.1.12 Alere Inc.

10.1.12.1 Business Overview

10.1.12.2 Product And Service Offerings

10.1.13 Abbott Laboratories

10.1.13.1 Business Overview

10.1.13.2 Product And Service Offerings

10.1.14 Randox Laboratories Ltd

10.1.14.1 Business Overview

10.1.14.2 Product And Service Offerings

10.1.15 Psychemedics Corporation

10.1.15.1 Business Overview

10.1.15.2 Product And Service Offerings

10.1.16 Bio-Rad Laboratories, Inc.

10.1.16.1 Business Overview

10.1.16.2 Product And Service Offerings

10.1.17 Sonic Healthcare Ltd.

10.1.17.1 Business Overview

10.1.17.2 Product And Service Offerings

10.1.18 Thermo Fisher Scientific Inc.

10.1.18.1 Business Overview

10.1.18.2 Product And Service Offerings

10.2 Strategic Developments: Drug of Abuse Testing Market

10.2.1 Mergers & Acquisitions

10.2.2 Partnerships

10.2.3 Product Launch And Approvals

10.2.4 Others

Chapter 11. Appendix

11.1 List of Abbreviations

Buy now this premium study – https://www.acumenresearchandconsulting.com/buy-now/0/384

About Us

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise

Media Contact
Company Name: Acumen Research and Consulting
Contact Person: Frank Wilson
Email: frank@acumenresearchandconsulting.com
Phone: +1 716-240-831
Country: United States
Website: https://www.acumenresearchandconsulting.com